Related Experiment Video
Updated: May 10, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
[Atrial fibrillation in cerebrovascular disease: national neurological perspective]
Joao Sargento-Freitas1, Fernando Silva, Sebastian Koehler
1Unidade de Acidente Vascular Cerebral, Serviço de Neurologia, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal. jsargentof@hotmail.com
Insights
Oral anticoagulation is underused in stroke prevention despite its proven efficacy. This study highlights the effectiveness of vitamin K antagonists in preventing secondary strokes, regardless of a patient's functional status.
Area of Science:
- Cardiology
- Neurology
- Public Health
Context:
- Atrial fibrillation is a growing cause of ischemic stroke with high embolic risk.
- Understanding stroke etiology and impact is crucial for effective management.
- Antithrombotic therapy plays a key role in secondary stroke prevention.
Purpose:
- To determine the frequency of atrial fibrillation in ischemic stroke patients.
- To analyze the impact of stroke from various causes.
- To evaluate pre- and post-stroke antithrombotic strategies.
Summary:
- A retrospective study of 631 ischemic stroke patients found a 34.5% cardioembolism rate, higher than literature.
- Mortality and morbidity were comparable to other series, indicating cardioembolic stroke severity.
- Oral anticoagulation, particularly vitamin K antagonists, was underused but effective in secondary prevention.
Impact:
- Confirms the clinical efficacy of vitamin K antagonists in secondary stroke prevention.
- Highlights the persistent underuse of oral anticoagulation despite guidelines.
- Demonstrates that anticoagulation is effective regardless of post-stroke functional impairment.
Background:
Cardioembolism due to atrial fibrillation assumes a dominant etiologic role in cerebrovascular diseases due to its growing incidence, high embolic risk and particular aspects of clinical events caused. Our objectives are to analyze the frequency of atrial fibrillation in patients with ischemic stroke, study the vital and functional impact of stroke due to different etiologies and evaluate antithrombotic options before and after stroke.
Methods:
We conducted a retrospective study including patients admitted in a central hospital due to ischemic stroke in 2010 (at least one year of follow-up). Etiology of stroke was defined using the Trial of ORG 10172 in Acute Stroke (TOAST) classification, and functional outcome by modified Rankin scale. We performed a descriptive analysis of different stroke etiologies and antithrombotic medication in patients with atrial fibrillation. We then conducted a cohort study to evaluate the clinical impact of antithrombotic options in secondary prevention after cardioembolic stroke.
Results:
In our population (n = 631) we found superior frequency of cardioembolism (34.5%) to that reported in the literature. Mortality, morbidity and antithrombotic options are similar to other previous series, confirming the severity of cardioembolic strokes and the underuse of vitamin K antagonists. Oral anticoagulation was effective in secondary prevention independently from post-stroke functional condition.
Conclusions:
Despite unequivocal recommendations, oral anticoagulation is still underused in stroke prevention. This study confirms the clinical efficacy of vitamin K antagonists in secondary prevention independently from residual functional impairment.
Related Concept Videos
Hemorrhagic Stroke ll: Pathophysiology
Hemorrhagic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology
Ischemic Stroke l: Introduction
Cerebral Edema ll: Pathophysiology
Transient Ischemic Attack l: Introduction

